AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
AtaiBeckley shares soared 50% premarket on Thursday after a report that Eli Lilly was in talks to acquire the psychedelic drug developer as soon as this week.
July 16, 2026
Mexico economy likely rebounded in second quarter
Monte dei Paschi, Banco BPM working on deal with cash component, Bloomberg News reports
Nvidia to invest $5 billion in Ilya Sutskever's AI startup, source says
NTSB chair urges Congress to pass aviation safety legislation
Athletics prospect Ryan Lasko says feeling in his legs returning after collision with his teammate
Car show raises funds for a boy with a rare disease
Oregon town welcomes thousands for annual 'Stand by Me' celebration